Urinary cotinine and cotinine + trans-30-hydroxycotinine (TNE-2) cut-points for distinguishing tobacco use from nonuse in the United States: PATH study (2013-2014)

Kathryn C. Edwards, Tasmia Naz, Cassandra A. Stanton, Maciej L. Goniewicz, Dorothy K. Hatsukami, Danielle M. Smith, Lanqing Wang, Andrea Villanti, Jennifer Pearson, Benjamin C. Blount, Maansi Bansal-Travers, June Feng, Raymond Niaura, Michelle T. Bover Manderski, Connie S. Sosnoff, Cristine D. Delnevo, Kara Duffy, Arseima Y. Del Valle-Pinero, Brian L. Rostron, Colm EverardHeather L. Kimmel, Dana M. van Bemmel, Andrew Hyland

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Urinary cotinine and cotinine + trans-3<sup>0</sup>-hydroxycotinine (TNE-2) cut-points for distinguishing tobacco use from nonuse in the United States: PATH study (2013-2014)'. Together they form a unique fingerprint.

Medicine & Life Sciences